These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 269416)

  • 21. Evaluation of the alpha and beta adrenoceptor-mediated activities of the novel, orally active inotropic agent, ibopamine, in the cardiovascular system of the pithed rat: comparison with epinine and dopamine.
    Nichols AJ; Ruffolo RR
    J Pharmacol Exp Ther; 1987 Aug; 242(2):455-63. PubMed ID: 3039117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vasomotor response of cerebral blood vessels to dopamine and dopaminergic agonists.
    Edvinsson L; Hardebo JE; McCulloch J; Owman C
    Adv Neurol; 1978; 20():85-96. PubMed ID: 676925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of dopamine on intestinal vessels in anesthetized dogs.
    van Kesteren RG; van Alphen MM; Charbon GA
    Circ Shock; 1988 May; 25(1):41-51. PubMed ID: 3402051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of some renal and cardiovascular effects of a prostaglandin analog, SKF 82526 and ibopamine in anesthetized dogs.
    Seymour AA; Blaine EH
    Arch Int Pharmacodyn Ther; 1984 Jun; 269(2):304-15. PubMed ID: 6148046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C(2)-Methylation abolishes DA1 dopamine agonist activity of 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (6,7-ADTN): steric intolerance by the receptor.
    Nichols DE; Jacob JN; Hoffman AJ; Kohli JD; Glock D
    J Med Chem; 1984 Dec; 27(12):1701-5. PubMed ID: 6502600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal vasodilation by a prostaglandin analog during dopaminergic and alpha-adrenergic blockade.
    Seymour AA; Blaine EH
    Prostaglandins Leukot Med; 1983 Mar; 10(3):349-60. PubMed ID: 6133286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conformational analogues of dopamine. Synthesis and pharmacological activity of (E)- and (Z)-2-(3,4-dihydroxyphenyl)cyclopropylamine hydrochlorides.
    Erhardt PW; Gorczynski RJ; Anderson WG
    J Med Chem; 1979 Aug; 22(8):907-11. PubMed ID: 40027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization.
    Dishy V; Sofowora GG; Xie HG; Kim RB; Byrne DW; Stein CM; Wood AJ
    N Engl J Med; 2001 Oct; 345(14):1030-5. PubMed ID: 11586955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of responses to dopamine in the mesenteric vascular bed of the cat.
    Lippton HL; Meyer RL; Parey SE; Hyman AL; Kadowitz PJ
    Arch Int Pharmacodyn Ther; 1981 May; 251(1):136-49. PubMed ID: 6114715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DIRECT RENAL VASODILATATION PRODUCED BY DOPAMINE IN THE DOG.
    MCNAY JL; MCDONALD RH; GOLDBERG LI
    Circ Res; 1965 Jun; 16():510-7. PubMed ID: 14299503
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of epinine on tension of human renal arteries.
    Schwinger RH; Schulz C; Brixius K; Böhm M; Müller-Ehmsen J; Erdmann E
    Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):343-7. PubMed ID: 8878065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mesenteric blood flow response to dopamine infusion during myocardial infarction in the awake dog.
    Hirsch LJ; Rone AS
    Circ Shock; 1983; 10(2):173-8. PubMed ID: 6839426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and renal vasodilator activity of 2-chlorodopamine and N-substituted derivatives.
    McCarthy JR; McCowan J; Zimmerman MB; Wenger MA; Emmert LW
    J Med Chem; 1986 Sep; 29(9):1586-90. PubMed ID: 3528490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of dopamine in the renal vascular bed of fetal, newborn, and adult sheep.
    Nakamura KT; Felder RA; Jose PA; Robillard JE
    Am J Physiol; 1987 Mar; 252(3 Pt 2):R490-7. PubMed ID: 2881489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modification of certain vascular responses to dopamine by morphine.
    Dressler WE; D'Alonzo G; Rossi GV; Orzechowski RF
    Eur J Pharmacol; 1974 Sep; 28(1):108-13. PubMed ID: 4430315
    [No Abstract]   [Full Text] [Related]  

  • 36. Characterization of vascular dopamine receptors in the gastric circulation of the rabbit.
    Reinsberg J; Kullmann R
    J Cardiovasc Pharmacol; 1986; 8(5):1067-73. PubMed ID: 2429081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo analysis of adrenergic receptor activity of dobutamine.
    Robie NW; Nutter DO; Moody C; McNay JL
    Circ Res; 1974 May; 34(5):663-71. PubMed ID: 4826937
    [No Abstract]   [Full Text] [Related]  

  • 38. Selective blockade of dopamine-induced vasodilation by ergonovine maleate in the vasculatures of dogs and rabbits.
    Roby A; Orzechowski RF
    Res Commun Chem Pathol Pharmacol; 1978 Feb; 19(2):243-56. PubMed ID: 644121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological profile of ibopamine. A summary of experiments on anaesthesized dogs.
    Marchetti GV
    Cardiology; 1990; 77 Suppl 5():22-9. PubMed ID: 1980631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased nutrient blood flow during dopamine- and epinephrine-induced intestinal vasodilation.
    Giraud GD; MacCannell KL
    J Pharmacol Exp Ther; 1984 Jul; 230(1):214-20. PubMed ID: 6747827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.